Novavax CEO to Present at the World Vaccine Congress 2008

ROCKVILLE, Md., April 21 /PRNewswire-FirstCall/ -- Novavax, Inc. NASDAQ: NVAX a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the World Vaccine Congress 2008 at 11:25 a.m. on April 23, 2008 in Washington D.C. Dr. Singhvi will provide an overview of the company's strategy, research and development progress.

Novavax has also been nominated as a Finalist for the Vaccine Industry Excellence (VIE) Awards 2008 in the 'Best Start Up' Category. The winner will be announced during the World Vaccine Congress Awards ceremony.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, highly potent, recombinant vaccines utilizing a new, efficient manufacturing solution.